I love blogging and I love reading other people's blogs. But I have a few peeves (of which I cannot claim I have never committed) that just irritate me.Select the correct word. There is a huge difference between they're, their, and there; and reign and rein; and its and it's. And I can go on. If you aren't sure, look it up ondictionary.com orthesaurus.com for help. It will really help people decipher what you are writing about.Spelling, spelling, spelling. If your blog app indicates a word is wrong or autocorrects to something you don't understand, correct it. How many people's resumes include the term that they were the'manger'of a department because the omitted'a'in manager becomes manger. Or when I worked for a legal non profit the omitted'l'in public. Punctuation wasn't taught as an optional part of studying the English language. Its important. Run on sentences are one thing. But if you type an entire paragraph without using a single comma something might be incorrect.I am not perfect. My high school English teacher told me I would never be a writer. Through my career I have done a lot of editing other people's writings and have learned the importance usage, spelling and punctuation. After I write each blog post I usually go back and read it before posting. I have also been known to reread earlier posts and go back and make corrections.A blog may be the result of a stream of consciousness that just pours out. But editing is usually required.... But keep wri...
Among women with metastatic breast cancer, use of an investigational oral form of paclitaxel yielded a higher overall response rate than the IV form, but administration was unique and time-consuming.Medscape Medical News
Publication date: Available online 12 December 2019Source: The LancetAuthor(s): Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Simon Cawthorn, Robert E Mansel, Sibylle Loibl, Bernardo Bonanni, D Gareth Evans, Anthony Howell, IBIS-II investigatorsSummaryBackgroundTwo large clinical trials have shown a reduced rate of breast cancer development in high-risk women in the initial 5 years of follow-up after use of aromatase inhibitors (MAP.3 and International Breast Cancer Intervention Study II [IBIS-II]). Here, we report blinded long-term follow-up results for the IBIS-II trial, which compared anastrozole with placebo...
ConclusionSingle isocenter technique was not feasible as the telecobalt unit did not have multileaf collimators and asymmetric jaws. With improved image based planning, a multi-isocentric technique was planned. By evaluating the dose distribution, beam modifications can be made and treatments can be given with acceptable toxicity.
Estrogen alone and estrogen/progestin have opposite effects on breast cancer risk; adding progestin may lead to a lifetime of increased risk.Medscape Medical News
Women who use certain types of hormones after menopause may still have an increased risk of developing breast cancer nearly two decades after they stop taking the pills
In postmenopausal women, breast cancer incidence down with estrogen alone, up with CEE + MPA
In conclusion, we identified and mechanically confirmed that AK4 is a novel therapeutic target of HER2-positive breast cancer. PMID: 31827645 [PubMed - in process]
More than 27,000 women in the US were given a hormone replacement therapy or a placebo - oestrogen-only HRT was found to reduce cancer risk by 23 per cent while combined HRT raised it.
Conclusions: The improved lesion segmentation method gives more precise lesion edge, which not only saves the time of automatic extraction of lesion region of interest without threshold setting for each case, but also prevents the segmentation error by manual and prejudice from different radiologists. The feature selection algorithm of multimodel-based recursive feature elimination has the ability to find robust and optimal features that distinguish the four molecular subtypes from image phenotypes. The gradient boosting decision tree classifier rather plays a main role in recognition than other models used in this paper. ...
A new tool could make it easier to predict whether early-stage triple-negative breast cancer will return following chemotherapy, according to results of a trial using a liquid biopsy to detect circulating tumor DNA.